By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and progressing understanding of existing drugs.

While CRISPR/Cas9 is the most versatile of these systems it has also ... as HIV-1 excision therapy will likely require multiple gRNAs delivered simultaneously, it is important to screen for large ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

It's clear though that these companies need time. Even with the only approved CAS9 based treatment out there, CRISPR is still years away from achieving its potential. In a recent update to ...

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

ZUG, Switzerland and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

A genome-wide CRISPR/Cas9 screen identifies VLDLR as entry receptor for SFV4. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-55493-3 ...